Reach Us +44-1647-403003
The Role of Chemotherapy in the Treatment of Kaposi's Sarcoma | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

The Role of Chemotherapy in the Treatment of Kaposi's Sarcoma

I.Essadi1*, Y.Sbitti1, M.Ichou1 and H.Errihani2

1Medical Oncology Unit at Military Hospital Mohamed V-R abat

2Medical Oncology Unit at National Institute of Oncology- Rabat

*Corresponding Author:
Dr. Essadi Ismail
Service d'oncologie médicale à l'hopital militaire d'instruction Mohamed V, 10100, Rabat, Maroc
Tel : (+212) 661168987
E-mail: [email protected]

Received Date: April 23, 2011; Accepted Date: July 20, 2011; Published Date: July 22, 2011

Citation: Essadi I, Sbitti Y, Ichou M, Errihani H (2011) The Role of Chemotherapy in the Treatment of Kaposi's Sarcoma. J Cancer Sci Ther 3: 145-148. doi:10.4172/1948-5956.1000077

Copyright: © 2011 Essadi I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Kaposi’s sarcoma (KS) is an opportunistic tumor proliferation Multicenter cells derived from lymphatic endothelium, infected with human herpes virus 8 (HHV-8). It is a heterogeneous disease distribution, which can be linked to poor prognosis. HHV-8 infection and immunosuppression are essential to its development [1,2]. These two elements are constant in the four clinical-epidemiological forms of KS: classical form, originally described by Moritz Kaposi typically affecting elderly men of Mediterranean, the endemic presence in Southern Africa, the epidemic form in patients infected HIV, and, finally, the MK complicating iatrogenic immunosuppression, particularly after organ transplantation [3]. This work exposes the real place of chemotherapy in adult patients with Kaposi sarcoma, among the available therapeutic means.


Share This Page